Recombinant CTLA-4 (Ipilimumab Biosimilar) anticorps

N° du produit ABIN7675654

Cet anticorps anti-CTLA-4 (Ipilimumab Biosimilar) est un anticorps Human Monoclonal détectant CTLA-4 (Ipilimumab Biosimilar) dans FACS, ELISA, BLI, Func et SPR. Adapté pour Humain.

Aperçu rapide pour Recombinant CTLA-4 (Ipilimumab Biosimilar) anticorps (ABIN7675654)

Antigène: CTLA-4 (Ipilimumab Biosimilar)

Type d'anticorp: Recombinant Antibody

Reactivité: Humain

Hôte: Human

Clonalité: Monoclonal

Conjugué: Cet anticorp CTLA-4 (Ipilimumab Biosimilar) est non-conjugé

Application: Flow Cytometry (FACS), ELISA, Bio-Layer Interferometry (BLI), Functional Studies (Func), Surface Plasmon Resonance (SPR)

Détail du produit anti-CTLA-4 (Ipilimumab Biosimilar) anticorps

Expression System: CHO Cells

Fonction: Anti-CTLA-4 / CD152 Reference Antibody (ipilimumab)

Attributs du produit: Anti-CTLA-4 / CD152 Reference Antibody (ipilimumab) is expressed from CHO. The heavy chain type is huIgG1, and the light chain type is hukappa. It has a predicted MW of 145.2 kDa.

Pureté: >95 %

Isotype: IgG1

Information d'application

Indications d'application: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Stockage

Format: Lyophilized

Concentration: 1 mg/mL

Buffer: 25 mM histidine, 8 % sucrose, 0.01 % Tween80 pH 6.2

Stock: 4 °C,-80 °C

Stockage commentaire: +4°C,-80°C

Détails sur CTLA-4 (Ipilimumab Biosimilar)

Antigène: CTLA-4 (Ipilimumab Biosimilar)

Classe de substances: Biosimilar

Poids moléculaire: 145.2 kDa

UniProt: P16410